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An advantage of the use of hyperthermia in the
treatment of malignant disease when external
heating sources are used is that there may be a
degree of preferential heating of a tumour over
surrounding normal tissues. This can be as a result
of differences between the tumour vasculature and
that of normal tissues (Field & Bleehen, 1979). The
general asumption that tumours are less well
perfused than normal tissues is by no means always
the case (Beaney et al., 1984), but as a result of
several interrelated factors tumour vasculature may
differ in its response to that of surrounding tissues.
Reports indicate that even with initially well
prefused tumours, following hyperthermia it is
likely that the tumour vasculature has a limited
capacity to dilate. Complete collapse and
coagulation probably occurs in these vessels at
lower temperatures and following a shorter
exposure to heat than normal vessels. This leads to
a relatively poorly perfused and therefore
preferentially heated tumour area (Song, 1981). The
end point of these various vascular effects is a
reduction in perfusion of the tumour. We have
investigated one aspect of this by studying the
effects of the rate of perfusion on heating using
perfused isolated rabbit lungs which can be
implanted into anaesthetised animals to simulate a
perfused tumour. We feel that this model simulates
the effect of perfusion more closely than previously
described dynamic phantoms (Cetas, 1981).
New Zealand white rabbits of between 2kg and
2.5kg were premedicated with fentanyl 0.2mg and
fluanisone 10mg (Hypnorm), and 2,000iu of
heparin injected IV via an ear vein just prior to the
administration of a lethal dose of 200mg of
pentobarbitone (Euthatal) IV. Following sacrifice of
the animals the chest was opened, the thymus
removed and a ligature placed around the
pulmonary trunk and the aorta. A catheter was
inserted into the pulmonary trunk through an
incision in the right ventricle and the ligature tied,
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thus tying off the aorta and securing the catheter in
place. A balloon catheter (Foley 18G) was inserted
through an incision in the left ventricle so that its
tip lay in the left atrium and the balloon partially
inflated to secure it in the left ventricle. The
preparation was flushed with 500ml of prewarmed
haemaccel (Hoechst) containing a further 2,000iu
of heparin, during which time the blood was
washed out of the lungs which change colour from
pink to white. A catheter was tied in place in the
trachea and the heart and lungs dissected out from
the rabbit. The preparation thus obtained could
then be used either as a perfused tissue phantom or
as an implantable tumour model.
For use as a phantom the lungs were partially
inflated and thermocouples were placed between the
lobes where they were in close apposition to
perfused tissue. They did not penetrate the lung
tissue as this would have led to a disruption of the
vasculature and fluid leakage. The preparation was
placed in a water bath at 37°C in which there was a
reservoir of preheated haemaccel which was
pumped through it. Heating was then achieved
using a clinical 915 MHz or 433 MHz microwave
system (Sathiaseelan et al., 1983). During a
constant power input the rise in temperature at
different flow rates could be monitored.
Alternatively the preparation could be perfused
whilst a second rabbit was prepared. A similar sized
animal was sedated and anaesthetised with
intermittent IV pentobarbitone (Sagatal 10%, May
and Baker), given via an ear vein. The abdomen
was shaved, a midline incision made and a short
length of bowel withdrawn from the abdominal
cavity and the rest retracted, thus leaving a space
where the lung preparation could be inserted to lie
in the flank of the animal. Thermocouples were
placed between the lobes of the preparation, above
and below it, and between the peritoneum and skin.
The retracted small bowel was replaced and an
attempt made to place a loop of bowel between the
preparation and the peritoneum. The thermo-
couples and cannulae to the preparation were
brought out of the abdomen through the wound
which was sutured closed in layers. Skin and rectal
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thermocouples were then placed in position. The
perfused preparation thus became a palpable
"tumour" in the flank of the anaesthetised rabbit
and could be heated by 433 MHz microwaves using
a 10cm x 20cm applicator (Tagmed Inc, USA)
placed over the swelling. At a constant power input
the temperature at various sites was monitored at
different rates of flow, the temperatures being
allowed to stabilise prior to taking readings at each
flow rate. At the end of the experiment the animal
was killed with a lethal dose of 200mg
pentobarbitone (Euthatal). Microscopy of sections
of the lung preparation following dye infusion at
the end of experiments showed the alveolar
architecture to be intact and staining predominantly
within the vascular tree.
We have tested this system in 15 experiments,
and the results of two such experiments are shown.
The flow values in both examples have been
corrected from absolute flow rates through the
preparation to mlmin1 1 I00g 1, the lungs being
weighed after the experiment. Figure 1 shows a
typical example of the flow versus temperature
curve where the preparation is used as a perfused
phantom. This shows that for relatively low flow
rates where the curve becomes very steep a small
differential between tumour and normal tissue may
lead to significant preferential heating of the
tumour. At higher flow rates, however, the graph
flattens and a much greater difference will be
necessary to gain a significant heating advantage.
Figure 2 shows the results of an abdominal
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Figure 1 The effect of reduction of rate of flow on,temperature rise in an extracorporeal perfused rabbit lung.
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Figure 2 The effect of reduction of flow on temperature rise in a perfiused r-abbit lung implanted within the
abdomen of an anaesthetised rabbit. Thermocouple no. 1, (0) rectal; no. 2, (FL) underneath lung preparation;
no. 3, (A) within lung preparation; no. 4, (0) subcutaneous; no. 5, (A) on skin surface.A PERFUSED BIOLOGICAL PHANTOM AND TUMOUR MODEL 281
tumour model experiment. It can be seen that the
core temperature, as monitored by a rectal probe
well outside the microwave applicator field, rose
uniformly as the flow was reduced. This was a
gradual rise in core temperature with time as the
high flow readings were monitored first and flow
gradually reduced. Thus by the end of the
experiment, which lasted 1 h, when the flow was
zero the core temperatures had risen by -2.5°C.
This gradual rise was also seen in the other
thermocouples shown and was not a flow effect but
a result of the relatively large size of applicator and
therefore the heated volume compared to the size of
the animal. Superimposed on this whole body
hyperthermia the characteristic steep curve seen in
Figure 1 was present in thermocouple 3, which was
within the implanted "tumour". Thermocouples
placed above (no. 4) and below (no. 2) the
implanted lung showed the same shape of curve as
thermocouple 3, demonstrating that the relatively
large bulk of the lung preparation was capable of
cooling the surrounding volume of abdomen. Apart
from the rectal monitor, the only thermocouples
consistently to show some temperature variation
from those within and around the "tumour" were
those on the skin surface (no. 5). No skin cooling
was used and thus initially skin temperatures were
higher than those in the intra-abdominal "tumour".
At low flow rates however the curves crossed with
the tumour temperature becoming higher than that
of the skin. This occurred only at flows below
10ml min-100g -. At higher flows conduction
from the relatively large "tumour" volume controls
the skin temperature. At low flow rates the greater
heating of the tumour is probably due to the
normal vasculature of the skin preferentially
cooling this area. The fact that curve starts to
steepen at lower flow rates than in the isolated
preparation is probably explained by variation in
the position of the thermocouples with respect to
the applicator.
This particular model obviously has limitations,
having a specialised vasculature and modelling only
one tumour size. The heating system required to
heat this "tumour" leads to whole body, rather
than just local hyperthermia. However, this model
demonstrates the possibility of preferential heating
of tumours as a result of a perfusion effect. At low
flow rates as may be expected in the centre of a
necrotic tumour, where the curve is steep, a small
differential in blood flow may lead to marked
temperature variations.
In summary, the implanted tumour model
demonstrates the same features as were seen in the
extracorporeal perfused phantom, and although
there are severe limitations to this particular model,
we suggest that at low "tumour" flow rates the
normal skin vasculature response to heat leads to a
preferential heating of the tumour model. This
model may be used to test thermal distributions
associated with hyperthermia techniques aimed at
heating tumours at depths in the host.
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